FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
Psychology Today1d
Mental Health and the Inflamed Brain
Encephalitis survivors experience hidden mental health struggles and there is an urgent need for improved support within the ...
Asia News Network3d
Controlled drug Ketamine a lifeline for patients with severe depression in Singapore
Since October 2020 – when the Health Sciences Authority (HSA) first authorised sale of an esketamine nasal spray for serious depression – five psychiatrists who used the therapy on their patients have ...
Psychology Today5d
New Strategies for Treatment-Resistant Depression
Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...